Malaria in Middle Childhood and Adolescence by Brooker, SJ et al.
  183
Malaria in Middle Childhood and Adolescence 
Simon J. Brooker, Sian Clarke, Deepika Fernando, 
Caroline W. Gitonga, Joaniter Nankabirwa, 
David Schellenberg, and Brian Greenwood
Chapter 14
INTRODUCTION
The age distribution of cases of malaria is influenced by 
the intensity of transmission. In areas where the popu-
lation has low exposure to infection, malaria occurs in 
all age groups. In high transmission areas, in contrast, 
the main burden of malaria, including nearly all malar-
ia-related deaths, is borne by young children (figure 
14.1). These different age patterns are seen because 
exposure to repeated malaria infections induces some 
protection against subsequent attacks; but protection is 
rarely complete.
The age pattern of clinical malaria is determined by 
the level of transmission and the consequent level of 
acquired immunity, so it is sensitive to changes in the level 
of transmission (Carneiro and others 2010; Snow and 
others 1997). In many malaria-endemic areas, successful 
control programs have reduced the level of transmission 
substantially (Noor and others 2014; O’Meara and others 
2010; WHO 2015). Consequently, in such communities, 
the peak age of clinical attacks of malaria is shifting from 
very young to older children. In The Gambia, the peak age 
of hospital admission for severe malaria increased from 
3.9 years in 1999–2003 to 5.6 years in 2005–07 (Ceesay 
and others 2008); similar changes have been seen in 
Kenya (O’Meara and others 2008).
If the financial support for malaria control continues, 
further decreases in the intensity of transmission can be 
anticipated in many highly endemic areas; these decreases 
will increase the incidence of clinical attacks of malaria, 
including severe attacks, in school-age children (ages 
5–14 years). However, the epidemiology and manage-
ment of malaria in school-age children has, until recently, 
received little attention. This chapter reviews the current 
burden of malaria in school-age children, its clinical 
consequences, and approaches to controlling the disease 
in this increasingly vulnerable group. The review focuses 
largely on Sub-Saharan Africa, in part because this 
region has the greatest burden of malaria in school-age 
children, but also because of the lack of information on 
the impact of malaria in school-age children in other 
parts of the world, including those where Plasmodium 
vivax is the dominant malaria parasite. An earlier version 
of the review has been published (Nankabirwa, Brooker, 
and others 2014). Definitions of age groupings and 
age-specific terminology used in this volume can be 
found in chapter 1 (Bundy, de Silva, and others 2017).
PREVALENCE OF MALARIA PARASITEMIA IN 
SCHOOL-AGE CHILDREN
The burden of malaria in school-age children is poorly 
defined because this age group is not routinely included 
in household-based cluster surveys. Information on 
the prevalence of malaria in this group is derived 
mainly from school-based surveys and from World 
Health Organization (WHO) estimates (WHO 2015). 
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Understanding the burden of malaria among school-age 
children is essential to justify investment in school-
based malaria control interventions (Bundy and others 
2000) and to identify delivery mechanisms to help 
 control malaria in this underserved population.
More than 500 million school-age children worldwide 
are at risk of malaria infection; 200 million of those at 
risk live in Sub-Saharan Africa (table 14.1) (Gething and 
others 2011). Annex 14A, table 14.1 summarizes the 
results of studies on the prevalence of asymptomatic 
malaria parasitemia in this population. Map 14.1 shows 
the frequency with which malaria surveys have been 
undertaken in school-age children, with an increase in 
recent years in East Africa. Map 14.2 shows the prevalence 
observed in school-age children by geographical area.
The majority of malariometric surveys are con-
ducted in children ages 2–10 years. Relatively few 
studies have been undertaken in older school-age 
children in Sub-Saharan Africa, and many of those are 
out of date following improvements in malaria con-
trol. In general, higher prevalence rates have been 
observed in West and Central Africa than in East 
Africa, but a great deal of heterogeneity has been 
observed with rates ranging from less than 5 percent 
to greater than 50 percent in different surveys. Recent 
studies in Malawi have emphasized the burden of 
malaria in school-age children and the role that those 
children play in acting as a reservoir of infection 
(Mathanga and others 2015; Walldorf and others 
2015).
Few reports on the prevalence of asymptomatic 
malaria in school-age children outside of Sub-Saharan 
Africa are available (annex 14A, table 14.1). In the 
Republic of Yemen, Bin Mohanna, Bin Ghouth, and 
Figure 14.1 Age Distribution of Cases of Severe Malaria by Intensity of Malaria
Source: Roca-Feltrer and others 2010.
Note: The ﬁ gure shows the percentage distribution of each severe malaria syndrome by age for children under age 10 years according to seasonality and transmission intensity, such that the 
integral of the curve is equal to 100 percent of expected cases.
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Rajaa (2007) find a prevalence of 13 percent in children 
ages 6–11 years in the Hajr valley. In Latin America, 
malaria transmission is restricted to Amazonian areas 
and is uniformly low. In Brazil, Vitor-Silva and others 
(2009) find that P. vivax was more common than 
P.  falciparum among schoolchildren. On the Thai-
Burma border, Luxemburger and others (1994) find that 
10 percent of school-age children were infected, mainly 
with P. falciparum.
IMPACT OF MALARIA ON THE HEALTH AND 
DEVELOPMENT OF SCHOOL-AGE CHILDREN
Most school-age children with malaria parasitemia do 
not have any symptoms because they have acquired 
some immunity. However, asymptomatic infections 
can contribute to anemia and impairment of cognitive 
development. School-age children may be infected 
with a malaria parasite that expresses antigens to 
which they have not been exposed and to which they 
have little or no immunity; the result is the develop-
ment of symptoms such as fever and, more rarely, 
severe diseases such as cerebral malaria, life- 
threatening anemia, and death.
Mortality
The WHO estimates that there were approximately 438,000 
(range 236,000–635,000) deaths from malaria in 2015; 
90 percent of those deaths occurred in Sub-Saharan Africa 
(WHO 2015). A comprehensive review of  malaria-related 
deaths between 1980 and 2010 (Murray and others 2012) 
reports many more deaths than the WHO; the review esti-
mates that 6 percent to 9 percent of malaria deaths occur 
in children ages 5–14 years, corresponding to an annual 
figure in the range of 70,000–110,000 deaths. A lower 
malaria mortality rate was found in school-age children 
compared with younger children in Bangladesh and Sub-
Saharan Africa (Adjuik and others 2006). A  similar age 
pattern was found in India, with an estimated malaria- 
related death rate of 29 per 1,000 in children ages 5–14 
years, compared with 55 per 1,000 in children under age 5 
years in 2005 (Dhingra and others 2010).
Incidence of Clinical Malaria in School-Age Children
An estimated 214 million (range 149 million to 303 
million) cases of malaria occurred worldwide in 2015; 
more than 80 percent were in Sub-Saharan Africa (WHO 
2015). However, data on the incidence of clinical malaria 
in school-age children are scarce. Review of the limited 
Table 14.1 Estimated School-Age (5–14 Years) Population at Risk of Plasmodium falciparum Malaria in Millions by 
Region,a 2010
Region Unstable risk Stable risk Total
Andean Latin America 1.0 0.6 1.7
Caribbean 2.4 1.8 4.2
Central Asia 0.2 – 0.2
Central Latin America 3.9 2.3 6.2
Central Sub-Saharan Africa <0.1 26.1 26.1
East Asia 1.6 0.6 2.2
Eastern Sub-Saharan Africa 3.3 80.7 84.0
Middle East and North Africa 4.0 2.5 6.5
Oceania <0.1 1.4 1.4
South Asia 165.6 98.6 264.3
South-East Asia 37.8 31.6 69.4
Southern Sub-Saharan Africa 2.3 4.8 7.1
Tropical Latin America 4.6 1.7 6.3
Western Sub-Saharan Africa 1.6 86.8 88.4
World 228.5 339.5 568.0
Source: Adapted from Gething and others 2011; data provided by the Malaria Atlas Project (www.map.ox.ac.uk), with thanks to Pete Gething and Zhi Huang, University of Oxford.
Note: – = not applicable. Rows may not add precisely due to rounding.
a. Based on the Global Burden of Disease study, http://www.healthdata.org/sites/default/ﬁ les/ﬁ les/GBD_GBD2010_Regions_countries.pdf.
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information published indicates that annual incidence 
can vary from 0.03 to 2.7 cases per child per year, depend-
ing on the transmission setting (annex 14A, table 14.2). 
The limited data available suggest that it is not unusual 
for school-age children to experience one clinical attack 
of malaria severe enough to warrant treatment once 
every one to two years (Barger and others 2009; Clarke 
and others 2004; Nankabirwa and others 2010; Rohner 
and others 2010).
Malaria as a Cause of Anemia in School-Age Children
Anemia is a common problem among school-age 
 children in the tropics. Its etiology is usually multifacto-
rial, and the relative importance of different causes var-
ies from area to area. It is difficult to separate malaria as 
a causative agent from other factors, such as nutritional 
deficiencies, helminth infections, and HIV/AIDS, which 
often coexist in the same communities (Stephenson and 
others 1985). Many other cross-sectional surveys carried 
out in highly endemic areas have found a significant 
association between the prevalence of anemia and para-
sitemia, but these studies were conducted mainly among 
 preschool-age children.
The strongest evidence for the role of malaria as a 
cause of anemia in school-age children comes from the 
results of intervention studies with trials of intermittent 
preventive treatment (IPT) in school-age children show-
ing improvement in hemoglobin concentration in both 
East Africa (Clarke and others 2008; Nankabirwa and 
others 2010) and West Africa (Barger and others 2009; 
Clarke and others 2013; Tine and others 2011).
Overall, differentiating the effect of malaria on ane-
mia in school-age children from other confounding 
factors is difficult; the limited evidence available suggests 
that it has a significant role. Although administration of 
supplementary iron can increase the incidence of clinical 
attacks of malaria in some circumstances, most studies 
have shown only a modest effect (Ojukwu and others 
2009). The WHO and other health authorities (Raiten, 
Namasté, and Brabin 2011) recommend that iron 
 supplementation is indicated in areas in which iron 
Map 14.1 Location of Malaria Parasite Surveys in School-Age Children, 1985–2013
Source: Malaria Atlas Project (MAP), http://www.map.ox.ac.uk.
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deficiency is a major problem, even if these areas are 
endemic for malaria, provided that malaria control mea-
sures, such as distribution of insecticide-treated bednets 
(ITNs), are put in place at the same time.
Malaria as a Cause of School Absenteeism
The estimated annual loss of school time in Kenya attrib-
utable to malaria in 2000 was 4 million to 10 million school 
days (Brooker and others 2000). Because malaria is an 
important cause of school absenteeism, preventive efforts 
should significantly improve school attendance. In a ran-
domized clinical trial in Sri Lanka, Fernando and others 
(2006) report a 55 percent reduction in malaria incidence 
and a 62.5 percent reduction in school absenteeism among 
children who received chloroquine prophylaxis.
Despite the limited number of studies, the available 
evidence suggests that the cumulative effect of school 
absenteeism attributable to malaria for children in 
endemic areas is considerable, preventing children from 
achieving their full academic potential and causing a loss 
to the state with respect to its investment in education.
Impact of Malaria on Cognitive Function
Studies in Africa and Asia provide strong evidence that 
malaria can impair the cognitive function of school-age 
children (Fernando, Rodrigo, and Rajapakse 2010; 
Kihara, Carter, and Newton 2006). Descriptive studies 
have evaluated the impact of severe malaria, uncompli-
cated malaria, and asymptomatic parasitemia on various 
aspects of cognition.
In Kenya, a retrospective assessment of children ages 
six to nine years who had had an episode of cerebral 
malaria found significant differences in speech and lan-
guage and cognition, compared with the healthy control 
group (Carter, Mung’ala-Odera, and others 2005; Carter, 
Ross, and others 2005; Carter and others 2006); in 
Uganda, cerebral malaria was associated with persistent 
impairment of one or more cognitive domains 
Map 14.2 Prevalence of Malaria Parasitemia in School-Age Children in Sub-Saharan Africa
Percent
Source: Malaria Atlas Project (MAP), http://www.map.ox.ac.uk.
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Table 14.2 Summary of the Results of Recent Trials of Chemoprevention in School-Age Children 
Study 
setting Population Type Treatment regimen
Study 
drug
Protective efficacy
Source
Clinical 
malaria 
Percent 
(95% CI) 
Malaria 
parasitemia 
Percent (95% CI) 
Anemia 
Percent (95% CI)
Year-round transmission
Western 
Kenya 
6,735 children ages 5–18 
years; 30 schools
IPCs Treatment once every school term 
(3 treatments per year)
SP + AQ Not examined 89 (73–95) 48 (8–71) Clarke and others 2008
Sierra Leone 591 children ages 
6–14 years; 1 school
IPCs Treatment at month 0 and month 3 
(2 treatments per year)
SP Not examined No impact No impact Rohner and others 2010 
Uganda 780 children; 3 schools IPCs Single course of treatment; protective 
efficacy measured after 42 days
SP Not examined No impact No impact Nankabirwa and others 
2010SP + AQ Not examined 48.0 (38.4–51.2) Mean change Hb +0.37 
(0.18–0.56)
DP Not examined 86.1 (79.5–90.6) Mean change Hb +0.34 
(0.15–0.53)
Uganda 740 children; 1 school IPCs Treatment once a school term 
(4 treatments per year)
DP No impact 54 (47–60) No impact Nankabirwa, Wandera, 
and others 2014
IPCs Treatment once every month 
(12 treatments per year)
DP 96 (88–99) 94 (92–98) 40 (19–56)
Highly seasonal transmission
Mali 262 children ages 
5–10 years; 1 village
SMC Two treatments 8 weeks apart during 
the malaria season (2 treatments 
per year)
SP 36 (12–53) Not examined Not examined Dicko and others 2008 
Mali 296 children ages 
6–13 years; 1 village
SMC Two treatments 8 weeks apart during 
the malaria season (2 treatments 
per year)
SP + AS 66.6 80.7 59.8 Barger and others 2009
AQ + AS 46.5 75.5 54.1
Mali 1,815 children ages 6–14 
years; 38 schools
IPCs Single treatment at end of the malaria 
season (1 treatment per year)
SP + AS Not examined 99 (98–100) 38 (9–58) Clarke and others 2013 
Senegal 1,000 children under age 
10 years; 8 villages
SMC Two treatments given monthly toward 
end of malaria season (2 treatments 
per year)
SP + AQ 79 (10–96) 57 (5–81) 41 (18–58) Tine and others 2011
Note: AQ = amodiaquine; AS = artesunate; CI = conﬁ dence interval; DP = dihydroartemisinin-piperaquine; Hb = hemoglobin; IPCs = intermittent parasite clearance in schools; IST = intermittent screening and treatment; SMC = seasonal malaria 
chemoprevention; SP = sulphadoxine-pyrimethamine.
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(John and others 2008). Similar findings were recorded 
in Malawian children with retinopathy-positive cerebral 
malaria (Boivin and others 2011).
Cerebral malaria is not a prerequisite for cognitive 
impairment as a consequence of malaria infection; stud-
ies have suggested that uncomplicated episodes of malaria 
can adversely affect cognition. Studies in Sri Lanka show 
that school-age children scored significantly lower on 
tests of mathematics and language during an episode of 
clinical malaria than children in the control group 
(Fernando, de Silva, and Wickremasinghe 2003). In a 
study in Sri Lanka, Fernando and others (2003) find a 
negative correlation between mathematical and language 
skills and a past history of repeated attacks of malaria 
during the preceding six years among children ages 6–14 
years, even after correcting for socioeconomic factors. A 
history of one or more malaria attacks was associated 
with poor performance in mathematics and language in 
a cohort of 198 schoolchildren studied in Brazil (Vitor-
Silva and others 2009). A study of school-age children in 
Mali, where P. falciparum malaria predominates, reaches 
similar conclusions (Thuilliez and others 2010).
Many of the studies considered were primarily 
descriptive, and their results are open to potential con-
founding by social or economic factors not included in 
the analysis. Accordingly, the strongest evidence to sup-
port the view that malaria impairs cognitive function 
comes from intervention trials. In Sri Lanka, a random-
ized, placebo-controlled, double-blind trial of chloro-
quine prophylaxis in children ages 6–12 years showed 
that educational attainment improved and that school 
absenteeism was reduced significantly (p < 0.0001) in 
children who took chloroquine prophylaxis (Fernando 
and others 2006). Children in The Gambia ages 3–59 
months who were randomized to receive malaria pro-
phylaxis with dapsone-pyrimethamine or placebo during 
the malaria transmission season for three successive years 
(Greenwood and others 1988) were reassessed when 
their mean age was 17 years (Jukes and others 2006). 
Educational attainment was better in children who had 
received prophylactic treatment than in the placebo 
group, but the scores for the cognitive tests were not sig-
nificantly different between groups. Prophylaxis substan-
tially increased the school enrollment of girls. The 
intervention also reduced school drop out for students in 
government schools (Zuilkowski and Jukes 2014).
In a large, stratified, cluster-randomized,  double- 
blind, placebo-controlled trial conducted in schools in 
Kenya, IPT with sulphadoxine-pyrimethamine plus 
amodiaquine (SP + AQ) significantly improved sus-
tained attention of schoolchildren ages 10–12 years 
(Clarke and others 2008). Significant effects on sustained 
attention are also reported from a trial in schools in 
southern Mali (Clarke and others 2013).
Overall, these studies strongly suggest that both clin-
ical malaria and asymptomatic parasitemia can adversely 
affect the cognitive skills of school-age children, but the 
mechanism by which this occurs remains uncertain.
APPROACHES TO THE CONTROL OF 
MALARIA IN SCHOOL-AGE CHILDREN
A range of strategies is available for the control of malaria 
in this age group, delivered through schools or communi-
ties. The optimal approach to delivering interventions, 
including frequency and timing, and their ultimate 
 effectiveness will vary according to the local intensity of 
malaria transmission. Malaria interventions are best deliv-
ered as part of an integrated package, for example, as part 
of a school health program that also delivers deworming 
(see chapter 13, Bundy, Appleby, and others [2017]) or 
school feeding (chapter 12, Drake and others [2017]). 
Treatment of Clinical Attacks
Ease of access of school-age children to effective treat-
ment for clinical attacks of malaria is an essential 
 component of any effective national malaria control 
program. However, in many parts of Sub-Saharan Africa, 
geographic and financial barriers prevent children from 
obtaining rapid access to diagnosis and treatment (see 
volume 6, chapter 14, Babigumira and others 2017).
Schools can play a vital role in ensuring that their pupils 
obtain rapid access to diagnosis and treatment by provid-
ing appropriate health education activities in school, but 
information about the treatment of malaria is rarely part 
of the curriculum. A content analysis of school textbooks 
in nine endemic countries found that most included infor-
mation on modes of transmission, mosquitoes, and signs 
and symptoms of malaria, but little about ITNs or the 
need for prompt and appropriate treatment (Nonaka and 
others 2012). These findings suggest that improving text-
book content in accordance with the national malaria 
control strategy should become a priority.
Access to prompt treatment can be improved by pro-
viding antimalarials to schools and by training teachers 
to administer antimalarial treatments correctly. In the 
past, when first-line treatment was either chloroquine 
or SP given presumptively, training teachers to provide 
treatment was shown to be feasible and to reduce school 
absenteeism and malaria deaths (Afenyadu and oth-
ers 2005; Pasha and others 2003). However, the WHO 
now recommends diagnosis before any antimalarial 
CAHD_183-198.indd   189 14/11/17   12:27 PM
190 Child and Adolescent Health and Development
treatment is given (WHO 2015). Building on recent 
efforts to expand diagnosis and treatment of malaria 
outside of the formal health sector (Ansah and others 
2015), an ongoing study in Malawi is evaluating the 
impact on school attendance and health outcomes of 
training teachers to use rapid diagnostic tests (RDTs) 
(Witek-McManus and others 2015). If this approach is 
effective, operational issues, including supply chains, 
blood safety, and teacher attrition, will require careful 
consideration before the strategy is scaled up.
Vector Control
The main methods of vector control of malaria are 
ITNs, indoor residual spraying (IRS), and reduction of 
mosquito breeding sites.
Insecticide-Treated Nets
Strong evidence indicates that regular use of ITNs sub-
stantially lowers the risks of clinical malaria and all-cause 
mortality in children under age five years and reduces the 
burden of malaria among pregnant women (Lengeler 
2004; Lim and others 2011). For these reasons, large- scale 
ITN distribution programs initially focused on these two 
vulnerable groups. However, following appreciation of 
the indirect herd effect of a high level of ITN coverage in 
a community, the development of long- lasting ITNs, and 
an increase in the financial and political support for ITN 
programs, there has been a shift from prioritizing vulner-
able populations to protecting everyone with an ITN, 
including school-age children. However, an analysis of 
household surveys undertaken between 2005 and 2009 in 
18 African countries found that school-age children were 
the group least likely to sleep under an ITN the previous 
night; between 38 percent and 42 percent of school-age 
children were unprotected (Noor and others 2009). 
Similar low ITN usage has been observed among school-
age children in Cameroon (Tchinda and others 2012), 
Kenya (Atieli and others 2011), and Uganda (Pullan and 
others 2010) ( figure 14.2). Substantial progress in popu-
lation coverage with ITNs has been made since 2000, 
with more than 50 percent of the population of 
 Sub-Saharan Africa sleeping under ITNs in 2015; never-
theless, ITN use among those ages 5–19 years remains 
lower than among the population as a whole (WHO 
2015). Thus, even in countries with existing national 
policies of universal access to ITNs, school-based distri-
bution of nets could have a complementary short-term 
role in addressing this gap.
Few studies have investigated the efficacy of ITNs in 
school-age children. An early trial among children in a 
rural boarding school in central Kenya showed that 
sleeping under an untreated mosquito net following a 
round of effective antimalarial treatment reduced the 
incidence of clinical malaria by 97 percent, but it did 
not reduce anemia (Nevill and others 1988). A reduc-
tion in the incidence of malaria was shown in a ran-
domized trial of children ages 4–15 years in an area of 
low and unstable transmission on the Thai-Burmese 
border (Luxemburger and others 1994). In a rural area 
of western Kenya, where malaria transmission is peren-
nial and high, a community-based trial showed that 
ITNs halved the prevalence of anemia in girls ages 
12–13 years; ITNs were less effective in preventing 
 anemia among girls ages 6–10 years (Leenstra and 
 others 2003). Additional evidence provided by cross- 
sectional survey data suggests that net use among 
school-age children is associated with a 71 percent and 
43 percent lower risk of P. falciparum infection in 
Somalia (Noor and others 2008) and Uganda (Pullan 
and others 2010), respectively. An analysis of country-
wide data from school surveys in Kenya (Gitonga and 
others 2012) shows that ITN use was associated with a 
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Parasitemia and of Reported Use of a Bednet on the 
Previous Night in Uganda.
Source: Pullan and others 2010.
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reduction in the odds of malaria infection and anemia 
in coastal areas, where malaria transmission is low to 
moderate, and among boys in western lakeshore Kenya, 
where transmission is high. In addition, ITN use 
reduced the risk of parasitemia in the western highland 
epidemic zones and the risk of anemia in coastal areas 
where transmission is low.
As children become more independent with increas-
ing age, parents have less control over their bedtimes, 
where they sleep, and whether they use nets. Education 
targeted directly to older children, for example, through 
malaria education in schools, could increase regular use 
of ITNs among teenage children.
Indoor Residual Spraying
IRS, the application of long-acting insecticides to the 
walls and roofs of houses and, in some cases, public 
buildings and domestic animal shelters, is an effective 
method of malaria control. IRS implemented as a 
community-wide campaign can achieve substantial 
reductions in the incidence and prevalence of malaria 
infection in all age groups (Pluess and others 2010). 
Repeated IRS campaigns conducted between 1955 and 
1959 in the Pare-Taveta area of Tanzania were associ-
ated with a reduction in malaria parasitemia from 
73 percent to 7 percent in children ages 5–9 years, and 
from 62 percent to 4 percent in children ages 10–14 
years (Draper 1960). Targeted IRS conducted over 
12 months in the epidemic-prone Kenyan highlands 
halved the monthly prevalence of asymptomatic infec-
tion in school-age children and reduced the incidence 
of clinical disease (Zhou and others 2010). Studies 
that have investigated the impact of combining vector 
control with ITNs and IRS have produced mixed 
results, with some showing a benefit and others no 
added effect.
Reduction of Breeding Sites
Breeding sites of malaria anopheline vector mosquitoes 
can be controlled in some epidemiological situations 
through application of larvicides, introduction of pred-
ator species, and habitat destruction and drainage 
(Tusting and others 2013). However, achieving a sig-
nificant reduction in malaria transmission in many 
parts of Sub-Saharan Africa is difficult because of the 
multiplicity and changing nature of breeding sites of 
the main vector species, such as Anopheles gambiae 
(Fillinger and Lindsay 2011). It is unlikely that encour-
aging schoolchildren to destroy potential breeding sites 
of An. gambiae in school grounds will have any impact 
on the prevalence of malaria, although it could help 
reduce the numbers of other mosquito species, includ-
ing those that transmit dengue.
Malaria Chemoprevention
The two main approaches to the use of antimalarial 
drugs to prevent malaria infection are chemoprophylaxis 
and IPT.
Chemoprophylaxis
Chemoprophylaxis involves the regular administration 
of antimalarial drugs to those at risk over a sustained 
period to provide persistent, protective blood levels. 
Compelling evidence indicates the benefits of chemo-
prophylaxis in school-age children. A review of trials 
of malaria chemoprophylaxis in the population of 
 malaria-endemic areas reports significant health impacts 
in nearly all studies (Prinsens Geerligs, Brabin, and 
Eggelete 2003). Most of these studies focus on young 
children, but in 30 of the 36 trials that examined infec-
tion rates in children over age five years, reductions in 
malaria parasitemia ranged from 21 percent to 100 
percent (Prinsens Geerligs, Brabin, and Eggelete 2003). A 
2008 review confirms these findings (Meremikwu, 
Donegan, and Esu 2008). Chemoprophylaxis with 
chloroquine not only reduced the incidence of clinical 
malaria and absenteeism in Sri Lankan schoolchildren, it 
also significantly improved educational attainment 
(Fernando and others 2006).
Intermittent Preventive Treatment
An alternative to chemoprophylaxis is IPT, the periodic 
administration of a full therapeutic dose of an antima-
larial or antimalarial combination to groups at increased 
risk of malaria. IPT clears existing asymptomatic infec-
tions and prevents new infections during the period 
immediately after treatment when protective blood lev-
els are present. IPT is being evaluated in schoolchildren 
in two ways: intermittent parasite clearance in schools 
(IPCs) and seasonal malaria chemoprevention (SMC).
IPCs involves the administration of IPT on a periodic 
basis to schoolchildren, with the aim of clearing asymp-
tomatic malaria infections and aiding hematologic 
recovery during the ensuing malaria-free period. Studies 
that have evaluated IPCs in school-age children are sum-
marized in table 14.2. The first study of IPCs (called IPT 
in that study), conducted in schools in western Kenya, 
shows that IPCs with SP + AQ given once a term signifi-
cantly reduced malaria parasitemia and anemia and sig-
nificantly improved sustained attention (Clarke and 
others 2008). However, the spread of parasites resistant 
to SP, and the consequent withdrawal of SP and AQ in 
many East African countries, precluded further investi-
gation of IPCs using these drugs in this area. Studies 
using alternative drugs, including dihydroartemisinin-
piperaquine, conducted in a range of settings, show 
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effects on parasitemia, anemia, and clinical malaria sim-
ilar to those obtained with SP + AQ, with a protective 
efficacy ranging between 54 percent and 99 percent 
reduction in malaria infection, and 38 percent to 
60 percent reduction in anemia (Barger and others 2009; 
Clarke and others 2013; Nankabirwa and others 2010).
Several conclusions can be drawn from these studies.
• First, IPCs is highly effective in reducing the burden 
of malaria among school-age children.
• Second, the medication used for IPCs, and the tim-
ing of treatments, needs to be adapted to the local 
epidemiology.
• Third, IPCs is likely to be most effective in settings 
where a high proportion of children harbor asymp-
tomatic infections, where malaria is a major cause of 
anemia, or both.
Seasonal Malaria Chemoprevention
SMC involves administration of treatment on a monthly 
basis to coincide with the annual peak in malaria trans-
mission. This intervention is highly effective in reducing 
the incidence of clinical malaria and anemia in young 
children (Wilson 2011). In 2012, the WHO recom-
mended implementation of SMC for children under age 
five years in areas of the Sahel subregion of Africa with 
highly seasonal transmission. This recommendation is 
being implemented increasingly widely in countries of 
the Sahel. Although less extensively researched, and not 
yet recommended by the WHO, evidence suggests that 
SMC is as effective in school-age children as in children 
under age five years (Barger and others 2009; Dicko and 
others 2008; Tine and others 2011, 2014), and Senegal 
provides SMC to children up to age 10 years. 
Intermittent Screening and Treatment
An alternative to IPCs or SMC is intermittent screening 
and treatment (IST), an intervention in which individu-
als are screened periodically for malaria infection using 
an RDT, and those infected (whether symptomatic or 
not) are treated with a full course of an effective antima-
larial agent or combination of agents. A  population-based 
study of IST in Burkina Faso shows no impact on the 
incidence of clinical malaria in children under age five 
years or on malaria transmission (Tiono and others 
2013); a cluster randomized trial in schools on the coast 
of Kenya, where transmission is low to moderate, finds 
no impact on health or cognition (Halliday and others 
2014). Possible reasons for the absence of an impact in 
these studies are the inability of some of the currently 
available RDTs to detect low-density parasitemia, and the 
rapid rate of reinfection following treatment in the areas 
in which these studies were done. The potential of this 
approach to control malaria in school-age children needs 
further investigation.
Vaccination
Development of an effective malaria vaccine has proved 
to be a major challenge, despite the exploration of many 
innovative approaches. One vaccine (RTS,S/AS01) has 
shown partial efficacy in a large-scale Phase 3 clinical 
trial and was given a positive opinion by the European 
Medicines Agency in July 2015 (RTS,S Clinical Trials 
Partnership 2015). However, the duration of protection 
provided by RTS,S/AS01 is relatively short, and vaccina-
tion in early life is unlikely to provide protection that 
lasts into school age. Only very limited data are available 
on the safety and immunogenicity of RTS,S/AS01 in 
school-age children (Bojang and others 2005). RTS,S/
AS01 is the most advanced malaria vaccine, but several 
other vaccines are making steady progress (Schwartz and 
 others 2012); in the longer term, vaccination may have 
an important role in the prevention of malaria in school-
age children.
ECONOMICS OF MALARIA CONTROL IN 
SCHOOLS
Few economic analyses have evaluated malaria control 
among school-age children. A 2011 systematic review 
identified 48 studies that evaluated the cost-effectiveness 
of malaria interventions (White and others 2011), of 
which only two were conducted among school-age 
 populations. The first study evaluated the cost- 
effectiveness of community-wide IRS programs among 
children ages 2–15 years in southern Mozambique 
(Conteh and others 2004). The financial costs per person 
covered in the rural area and peri-urban areas were 
US$3.86 and US$2.41, respectively. Using health facility 
records to estimate the number of infections averted, the 
economic cost per case of malaria parasitemia averted 
among those ages 2–15 years was US$21.23.
The second study evaluated the cost-effectiveness of 
IPCs (Temperley and others 2008). The study estimated 
that the cost of IPCs delivered by teachers was US$1.88 
per child per year, with drug and teacher training consti-
tuting the largest cost components. The estimated cost 
per anemia case averted through IPCs was US$29.84, and 
the estimated cost per case of malaria parasitemia averted 
was US$5.36 (Temperley and others 2008). Another 
study investigates the cost of IST delivered through 
schools and estimates the cost of IST per child screened 
to be US$6.61 (Drake and others 2011). These estimates 
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of cost and cost-effectiveness fall within the range of 
per capita costs of other malaria control strategies 
(White and others 2011), but they are more expensive 
than school-based deworming programs. However, the 
simultaneous delivery by teachers of both IPCs 
and deworming as part of an integrated school health 
 package may yield economies of scope and increase 
cost-effectiveness. More studies are required on the 
cost-effectiveness of malaria control in schoolchildren.
It is also important to consider the effect of other 
ongoing malaria control measures because they will 
reduce malaria transmission in the wider community. 
In this situation, mathematical models of malaria can 
provide insight because they can simultaneously model 
multiple interventions and take into account the dynam-
ics of malaria transmission, especially the mass effects of 
community interventions. For example, modeling of the 
cost-effectiveness of community-wide IST highlighted 
its value in medium-high transmission settings among 
school-age children, but only if it was continued indefi-
nitely (Crowell and others 2013). The combined use of 
mathematical modeling and economic evaluation can 
help identify which interventions should be targeted 
specifically toward school-age children and which inter-
ventions should be delivered as part of community-wide 
malaria control.
CONCLUSIONS
On the basis of the available data, some recommendations 
can be made about the management of malaria in school-
age children (box 14.1), but much more needs to be learned 
about the effectiveness of different approaches (box 14.2).
Better data are needed on the burden of malaria in 
school-age children. A standardized approach to data 
collection would improve the ability to monitor progress 
in this at-risk group. Systems to capture episodes of clin-
ical and fatal malaria in school-age children do not need 
to be school based, but they should summarize data for 
this specific risk group.
The potential of serological tests to help in evaluating 
the burden of malaria in school-age children needs to be 
studied further. Improved information on the extent of 
the burden of malaria and on the socioeconomic conse-
quences of malaria in this age group would enhance 
awareness at multiple levels.
• Global level: Policy makers and multilateral funding 
organizations would pay more attention to this issue.
• National level: Interactions among education, health, 
and potentially other sectors would be catalyzed.
• Local and individual levels: Families that include 
schoolchildren would be better able to take the 
 necessary steps to prevent and treat malaria.
Operational research is needed to determine how best 
to raise awareness of the importance of malaria, how to 
manage it, and how to improve the use of established con-
trol measures in this group. Improving the malaria- 
relevant content of school curricula will help children help 
themselves and equip them with the understanding 
needed to accept new approaches to the control of malaria, 
such as the value of blood testing for parasitological diag-
nosis to guide appropriate treatment. School-age children 
can become an important route for disseminating infor-
mation on malaria control to the rest of the family.
Further studies are needed to understand the poten-
tial role of medications in preventing malaria in 
school-age children. Chemoprophylaxis, SMC, IPCs, 
and IST may all be beneficial, but it is not clear yet in 
which  settings each might be most effective or cost- 
effective. Some chemoprevention is likely to be useful 
in high transmission settings. The cost-effectiveness of 
chemoprevention is likely to be lower in low transmis-
sion settings, where most recipients are unlikely to 
have malaria. However, the transmission threshold at 
which to introduce, or withdraw, chemoprevention 
will only become clear through the modeling of 
empirical data. The optimal characteristics of drugs 
for SMC, IPCs, and IST are likely to include low cost, a 
very good safety profile, exceptional tolerability, long 
Box 14.1
Policy Recommendations for the Control of Malaria 
in School-Age Children
National malaria control programs need to pay increas-
ing attention to the problem of malaria in school-age 
children, as the proportion of cases of malaria in older 
children increases. Education about causes of malaria; its 
clinical features; and ways of diagnosing, treating, and 
preventing the infection should be an integral part of the 
curriculum of all schools in areas where the school-age 
population is at risk of malaria infection. All school-
age children in high-transmission areas need to sleep 
under  insecticide-treated bednets. School-age children 
who develop clinical malaria need to be able to recognize 
the nature of their illness and have easy and rapid access 
to reliable diagnosis and effective treatment, either in their 
schools or at nearby health facilities.
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half-life, and single-dose treatment. The development 
of a rigorous target product profile would help guide 
the development of drugs suitable for use in the pre-
vention of malaria in school-age children. The poten-
tial of IST programs to identify and help not only 
individuals but also communities at elevated risk of 
malaria warrants further exploration.
More effective control of malaria is only one part of 
the drive to improve the health and potential of school-
age children. More work is needed to determine how and 
when to integrate malaria control strategies with other 
school-based programs at the local and national levels.
ANNEX
The annex to this chapter is as follows. It is available at 
http://www.dcp-3.org/CAHD.
• Annex 14A. Estimates of Parasitemia and Clinical 
Disease among School-Aged Children in Africa
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